RedHill Biopharma (RDHL) Event Oct. 18, 2022, 11:05 UTC 19 1 comments (99% Neutral) RedHill Biopharma (RDHL) Announces Clinical Development Update (Form 6-K) Comment Full text
9 Meters Biopharma Inc. (NMTR) Event Oct. 18, 2022, 06:20 UTC 102 0 comments 9 Meters Biopharma to Present at the American College of Gastroenterology (ACG) 2022 Annual Scientific Meeting Comment Full text
KalVista Pharmaceuticals Inc (KALV) Event Oct. 17, 2022, 20:55 UTC 32 1 comments (75% Positive) KALVISTA PHARMACEUTICALS, INC. (KALV) Provides Update on Retire for Planned Transition - Cambridge Comment Full text
MacroGenics Inc (MGNX) Event Oct. 17, 2022, 20:22 UTC 31 1 comments (10% Negative) MACROGENICS, INC. (MGNX) Announces Delay in treatment Trials for certain blood cancers Due to Pandemic-Related Challenges, Patient Enrollment Issues, Regulatory Process, Efficacy Assessment Comment Full text
Rubius Therapeutics (company was delisted NASDAQ) (RUBY) Event Oct. 17, 2022, 20:05 UTC 27 1 comments (99% Neutral) RUBIUS THERAPEUTICS, INC. (RUBY) Announces Executive Departure Comment Full text
Legend Biotech (LEGN) Event Oct. 17, 2022, 20:02 UTC 18 1 comments (99% Neutral) Legend Biotech (LEGN) Files Form 6-K Comment Full text
Pfizer Inc (PFE) Event Oct. 17, 2022, 19:24 UTC 110 0 comments Pfizer Inc. - Pfizer Analyst and Investor Call to Review RSV Data Presented at ID Week 2022 Comment Full text
Sanofi (SNY) Event Oct. 17, 2022, 17:35 UTC 17 1 comments (10% Negative) Sanofi (SNY) Announces Clinical Development Update (Form 6-K) Comment Full text
QuantumSi Inc (QSI) Event Oct. 17, 2022, 14:06 UTC 108 0 comments Quantum-Si to Report Third Quarter 2022 Financial Results on November 7, 2022 Comment Full text
Athira Pharma Inc (ATHA) Event Oct. 17, 2022, 12:30 UTC 29 1 comments (10% Negative) Athira Pharma, Inc. (ATHA) Announces Clinical Trial Timeline Adjustment Comment Full text